Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.

Allscripts closed its acquisition of McKesson’s Enterprise Information Solutions business Oct. 2. Allscripts purchased the hospital and health system IT business for $185 million in cash, “subject to ...

Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2020 after the close of stock market hours on Thursday, ...

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and twelve months ended December 31, 2021. Bookings (1) were ...

Cassie is a former deputy editor who collaborated with teams around the world while living in the beautiful hills of Kentucky. Focusing on bringing growth to small businesses, she is passionate about ...

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2022. First quarter 2022 Veradigm ...

Allscripts will sell the net assets of its hospital business segment for up to $700 million to Constellation Software’s subsidiary, N. Harris Computer Corporation, the companies announced Wednesday ...

Health IT vendor Allscripts is selling its hospitals and large physician practices business segment to Canada-based Harris Computer Corporation, a subsidiary of holding company Constellation Software, ...

Allscripts is selling the net assets of its business segment for hospitals and large physician practices to N. Harris Computer Corp., a subsidiary of Constellation Software. The business segment ...

Allscripts Healthcare Solutions, Inc. MDRX is well poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust fourth-quarter 2021 performance and ...

Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2022 performance and ...